Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in coronary artery spasm
NCT06432452Phase 3Enrolling by invitation
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bosentan in coronary artery spasm (CAS), sponsored by Radboud University Medical Center. Started Nov 2024; status: enrolling by invitation.
02
Drugs
bosentan
03
Conditions
coronary artery spasm (CAS)
Beyond the preview
Go deeper on NCT06432452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06432452.